His research explores the intersection of neuroscience, pharmacology, and the nature of reality, with a particular focus on DMT and extended-state psychedelic experiences.

As a key collaborator with Dr. Rick Strassman, Gallimore co-developed the extended-state DMT pharmacokinetic model, a revolutionary method for sustaining DMT experiences in a controlled, medical setting—laying the foundation for DMTx. His book, Alien Information Theory: Psychedelic Drug Technologies and the Cosmic Game, presents a visionary framework for understanding how psychedelics influence human perception and cognition.

Currently based in Tokyo, Japan, Dr. Gallimore continues to push the boundaries of psychedelic science. His latest work, Reality Switch Technologies: Psychedelics as Tools for the Discovery and Exploration of New Worlds, expands on the potential of psychedelics as gateways to unexplored dimensions of consciousness.

At Eleusis, Dr. Gallimore’s pioneering research is at the core of our approach. His expertise ensures that DMTx is delivered in a scientifically precise, medically supervised, and profoundly transformative way—offering guests unparalleled access to the frontiers of consciousness.

Through his multidisciplinary approach, Gallimore challenges conventional paradigms, inspiring a deeper understanding of the mind and its untapped potential. His contributions to the field continue to reshape the future of psychedelic medicine, unlocking new possibilities for therapy, self-discovery, and human evolution.